CRDF R&D Expense Growth
Cardiff Oncology Inc · R&D Expense Growth
CRDF R&D Expense Growth
Latest reported-4.13%period ending
CRDF FY R&D Growth (YoY) (0.00% → -4.13%)
Latest values, visible window
High-resolution chart · PNG
CRDF r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -4.1327% | |
| 12.1587% | |
| 21.2122% | |
| 56.0025% | |
| 54.6595% | |
| 0.6519% | |
| 36.7251% | |
| 3.5646% | |
| -47.4712% | |
| 41.6557% | |
| 58.9497% | |
| 68.8372% | |
| 105.6036% | |
| 110.8303% | |
| -75.3271% | |
| 0% | |
| 0% | |
| 203.0947% | |
| 0% |